Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic performance of troponin in COVID-19: A diagnostic meta-analysis and meta-regression
Arief Wibowo, Raymond Pranata, Mohammad Rizki Akbar, et al.
International Journal of Infectious Diseases (2021) Vol. 105, pp. 312-318
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae
Leonardo Italia, Daniela Tomasoni, Stefano Bisegna, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 115
Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: A systematic review and meta-analysis of adjusted effect estimates
Januar Wibawa Martha, Raymond Pranata, Michael Anthonius Lim, et al.
International Journal of Infectious Diseases (2021) Vol. 108, pp. 6-12
Open Access | Times Cited: 49
COVID-19 and cardiovascular complications – the preliminary results of the LATE-COVID study
Joanna Lewek, Izabela Jatczak‐Pawlik, Marek Maciejewski, et al.
Archives of Medical Science (2021) Vol. 17, Iss. 3, pp. 818-822
Open Access | Times Cited: 46
COVID19 biomarkers: What did we learn from systematic reviews?
Sabina Semiz
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 31
Effective prognostic and clinical risk stratification in COVID‐19 using multimodality biomarkers
Alexander Liu, Robert Hammond, Peter Donnelly, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 1, pp. 21-46
Open Access | Times Cited: 15
Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2
Liselore De Rop, David AG Bos, Inge Stegeman, et al.
Cochrane library (2024) Vol. 2024, Iss. 8
Open Access | Times Cited: 5
The HEARRT-C Score: Is Aspirin Protective in COVID-19 Patients? A Single-Centre Retrospective Study
Zeynep Kumral, Ali Cantürk, Ahmet Anıl Başkurt, et al.
COVID (2025) Vol. 5, Iss. 2, pp. 21-21
Open Access
Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients
Luis García de Guadiana‐Romualdo, Mónica Martínez Martínez, María Dolores Rodríguez Mulero, et al.
International Journal of Infectious Diseases (2021) Vol. 111, pp. 211-218
Open Access | Times Cited: 33
Biomarkers Associated with Cardiovascular Disease in COVID-19
Christoph C. Kaufmann, Amro Ahmed, Achim Leo Burger, et al.
Cells (2022) Vol. 11, Iss. 6, pp. 922-922
Open Access | Times Cited: 22
Evaluation of various blood biomarkers associated with the outcomes of patients with COVID‑19 treated in intensive care units
Sıdıka Genç, Ali Taghizadehghalehjoughi, Muhammet Emin Naldan, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 2
Open Access | Times Cited: 4
Manifestations and Mechanism of SARS-CoV2 Mediated Cardiac Injury
Si‐Chi Xu, Wei Wu, Shuyang Zhang
International Journal of Biological Sciences (2022) Vol. 18, Iss. 7, pp. 2703-2713
Open Access | Times Cited: 20
Global burden of acute myocardial injury associated with COVID-19: A systematic review, meta-analysis, and meta-regression
Semagn Mekonnen Abate, Bahiru Mantefardo, Solomon Nega, et al.
Annals of Medicine and Surgery (2021) Vol. 68
Open Access | Times Cited: 25
Elevated De Ritis Ratio Is Associated With Poor Prognosis in COVID-19: A Systematic Review and Meta-Analysis
Raymond Pranata, Ian Huang, Michael Anthonius Lim, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 22
Dipeptidyl peptidase-4 (DPP-IV) inhibitor was associated with mortality reduction in COVID-19 — A systematic review and meta-analysis
Ahmad Fariz Malvi Zamzam Zein, Wilson Matthew Raffaello
Primary care diabetes (2021) Vol. 16, Iss. 1, pp. 162-167
Open Access | Times Cited: 21
A Real Pandora’s Box in Pandemic Times: A Narrative Review on the Acute Cardiac Injury Due to COVID-19
Amalia-Stefana Timpau, Radu-Ștefan Miftode, Daniela Leca, et al.
Life (2022) Vol. 12, Iss. 7, pp. 1085-1085
Open Access | Times Cited: 14
Successive Waves of the COVID-19 Pandemic Had an Increasing Impact on Chronic Cardiovascular Patients in a Western Region of Romania
Adelina Tudora, Diana Lungeanu, Adina Pop-Moldovan, et al.
Healthcare (2023) Vol. 11, Iss. 8, pp. 1183-1183
Open Access | Times Cited: 8
Quantification of hs-Troponin Levels and Global Longitudinal Strain among Critical COVID-19 Patients with Myocardial Involvement
Mochamad Yusuf Alsagaff, Louisa Fadjri Kusuma Wardhani, Ricardo Adrian Nugraha, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 352-352
Open Access | Times Cited: 2
Specific characteristics of STEMI in COVID-19 patients and their practical implications
Mauro Gitto, Laura Novelli, Bernhard Reimers, et al.
Kardiologia Polska (2022) Vol. 80, Iss. 3, pp. 266-277
Open Access | Times Cited: 13
Effect of colchicine on mortality in patients with COVID-19 – A systematic review and meta-analysis
Ahmad Fariz Malvi Zamzam Zein, Wilson Matthew Raffaello
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 2, pp. 102395-102395
Open Access | Times Cited: 12
Clinical characteristics and predictors for in-hospital mortality in adult COVID-19 patients: A retrospective single center cohort study in Vilnius, Lithuania
Ieva Kubiliute, Monika Vitkauskaitė, Jurgita Urbonienė, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0290656-e0290656
Open Access | Times Cited: 6
The Evaluation of Troponin I Levels and Myocarditis in Children with COVID-19: A Pediatric Single-Center Experience
Gizem Güner Özenen, Aybüke Akaslan Kara, Elif Kıymet, et al.
Pediatric Cardiology (2022) Vol. 44, Iss. 4, pp. 873-881
Open Access | Times Cited: 10
Normal high-sensitivity cardiac troponin for ruling-out inpatient mortality in acute COVID-19
Alexander Liu, Robert Hammond, Kenneth Chan, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0284523-e0284523
Open Access | Times Cited: 5
Diagnosis and treatment of cardiovascular manifestations of COVID-19: a narrative review
Eissa Bilehjani, Solmaz Fakhari, Haleh Farzin, et al.
Acta Cardiologica (2023) Vol. 79, Iss. 3, pp. 267-273
Closed Access | Times Cited: 5
Calprotectin Levels and Neutrophil Count Are Prognostic Markers of Mortality in COVID-19 Patients
Giovanna Cardiero, Daniela De Palma, Martina Vano, et al.
Diagnostics (2022) Vol. 12, Iss. 10, pp. 2554-2554
Open Access | Times Cited: 9
Association between echocardiographic features, troponin levels, and survival time in hospitalized COVID-19 patients with cardiovascular events
Stephen Furmanek, Vidyulata Salunkhe, Siddharth Pahwa, et al.
Journal of Anesthesia and Translational Medicine (2024) Vol. 3, Iss. 2, pp. 36-44
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top